Keloids and Hypertrophic Scars: A Spectrum of Clinical Challenges

Am J Clin Dermatol. 2016 Jun;17(3):201-23. doi: 10.1007/s40257-016-0175-7.

Abstract

Since their earliest description, keloids and hypertrophic scars have beleaguered patients and clinicians alike. These scars can be aesthetically disfiguring, functionally debilitating, emotionally distressing, and psychologically damaging, culminating in a significant burden for patients. Our current understanding of keloid pathophysiology has grown and continues to advance while molecular biology, genetics, and technology provide ever-deepening insight into the nature of wound healing and the pathologic perturbations thereof. Greater understanding will lead to the development and application of refined therapeutic modalities. This article provides an overview of our current understanding of keloids, highlighting clinical characteristics and diagnostic criteria while providing a comprehensive summary of the many therapeutic modalities available. The proposed mechanism, application, adverse events, and reported efficacy of each modality is evaluated, and current recommendations are summarized.

Publication types

  • Review

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Adjuvants, Immunologic / adverse effects
  • Adjuvants, Immunologic / therapeutic use
  • Aminoquinolines / administration & dosage
  • Aminoquinolines / adverse effects
  • Aminoquinolines / therapeutic use
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / therapeutic use
  • Antibiotics, Antineoplastic / administration & dosage
  • Antibiotics, Antineoplastic / adverse effects
  • Antibiotics, Antineoplastic / therapeutic use
  • Antimetabolites / administration & dosage
  • Antimetabolites / adverse effects
  • Antimetabolites / therapeutic use
  • Bleomycin / administration & dosage
  • Bleomycin / adverse effects
  • Bleomycin / therapeutic use
  • Cell Proliferation
  • Cicatrix, Hypertrophic* / etiology
  • Cicatrix, Hypertrophic* / pathology
  • Cicatrix, Hypertrophic* / therapy
  • Clinical Trials as Topic
  • Collagen / metabolism
  • Combined Modality Therapy / methods
  • Cryotherapy / methods
  • Extracellular Matrix / physiology
  • Fibroblasts / physiology*
  • Fluorouracil / administration & dosage
  • Fluorouracil / adverse effects
  • Fluorouracil / therapeutic use
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / adverse effects
  • Glucocorticoids / therapeutic use
  • Humans
  • Imiquimod
  • Inflammation / metabolism
  • Keloid* / etiology
  • Keloid* / pathology
  • Keloid* / therapy
  • Laser Therapy / methods
  • Wound Healing / physiology*

Substances

  • Adjuvants, Immunologic
  • Aminoquinolines
  • Anti-Inflammatory Agents
  • Antibiotics, Antineoplastic
  • Antimetabolites
  • Glucocorticoids
  • Bleomycin
  • Collagen
  • Imiquimod
  • Fluorouracil